Skip to main content
Erschienen in: Rheumatology International 5/2013

01.05.2013 | Short Communication

Decreased vitamin D levels in patients with familial mediterranean fever

Erschienen in: Rheumatology International | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Familial mediterranean fever (FMF) is an autosomal recessive disorder caused by mutations in the FMF gene (MEFV). The gene causing FMF, designated MEFV, encodes a protein called pyrin or marenostrin that is expressed mainly in myeloid bone marrow precursors, neutrophils, and monocytes. Since there are several etiological factors, FMF is the most common periodic fever syndrome. However, it is still unknown what triggers or ends these periodical attacks. As a pleiotropic hormone, vitamin D has immunomodulation effects. The aim of this study was to evaluate the vitamin D levels in FMF patients. The study group was comprised of 26 patients diagnosed with FMF (men/women: 12/14), and 34 healthy control (men/women: 17/17). Vitamin D levels in FMF patients and healthy controls were 11.05 ± 7.11, 17.15 ± 6.49, respectively. FMF patients had significantly decreased vitamin D levels compared with healthy controls (P < 0.001). In conclusion, it is thought that vitamin D deficiency in FMF patients may trigger the attacks. Further studies with larger patient populations need to hold to investigate the vitamin D deficiency in patients with FMF and that may assist to clarify the mechanism behind the colchicines resistant cases.
Literatur
1.
Zurück zum Zitat Sohar E, Gafni J, Pras M et al (1967) Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med 43(2):227–253PubMedCrossRef Sohar E, Gafni J, Pras M et al (1967) Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med 43(2):227–253PubMedCrossRef
2.
Zurück zum Zitat Centola M, Wood G, Frucht DM et al (2000) The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 95:3223–3231PubMed Centola M, Wood G, Frucht DM et al (2000) The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 95:3223–3231PubMed
3.
Zurück zum Zitat Lemire JM, Ince A, Takashima M et al (1992) 1, 25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity 12:143–148PubMedCrossRef Lemire JM, Ince A, Takashima M et al (1992) 1, 25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity 12:143–148PubMedCrossRef
4.
Zurück zum Zitat Cantorna MT, Munsick C, Bemiss C, Mahon BD et al (2000) 1, 25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 130:2648–2652PubMed Cantorna MT, Munsick C, Bemiss C, Mahon BD et al (2000) 1, 25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 130:2648–2652PubMed
5.
Zurück zum Zitat Cantorna MT, Hayes CE, DeLuca HF (1998) 1, 25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 128:68–72PubMed Cantorna MT, Hayes CE, DeLuca HF (1998) 1, 25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 128:68–72PubMed
6.
Zurück zum Zitat Oelzner P, Müller A, Deschner F, Hüller M, Abendroth K, Hein G, Stein G et al (1998) Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 62(3):193–198PubMedCrossRef Oelzner P, Müller A, Deschner F, Hüller M, Abendroth K, Hein G, Stein G et al (1998) Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 62(3):193–198PubMedCrossRef
7.
Zurück zum Zitat Szodoray P, Tarr T, Bazso A, Poor G, Szegedi G, Kiss E et al (2011) The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary. Scand J Rheumatol 40(2):122–126PubMed Szodoray P, Tarr T, Bazso A, Poor G, Szegedi G, Kiss E et al (2011) The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary. Scand J Rheumatol 40(2):122–126PubMed
8.
Zurück zum Zitat Hamzaoui K, Ben Dhifallah I, Karray E et al (2010) Vitamin D modulates peripheral immunity in patients with Behçet’s disease. Clin Exp Rheumatol Jul–Aug;28(4 Suppl 60): S50–S57 Hamzaoui K, Ben Dhifallah I, Karray E et al (2010) Vitamin D modulates peripheral immunity in patients with Behçet’s disease. Clin Exp Rheumatol Jul–Aug;28(4 Suppl 60): S50–S57
9.
Zurück zum Zitat Livneh A, Langevitz P, Zemer D et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885PubMedCrossRef Livneh A, Langevitz P, Zemer D et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885PubMedCrossRef
10.
Zurück zum Zitat Mosmann TR, Sad S (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138–146PubMedCrossRef Mosmann TR, Sad S (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138–146PubMedCrossRef
11.
Zurück zum Zitat Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383:787–793PubMedCrossRef Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383:787–793PubMedCrossRef
12.
Zurück zum Zitat Köklü S, Öztürk MA, Balcı M et al (2005) Interferongamma levels in familial Mediterranean fever. Jt Bone Spine 72:38–40CrossRef Köklü S, Öztürk MA, Balcı M et al (2005) Interferongamma levels in familial Mediterranean fever. Jt Bone Spine 72:38–40CrossRef
13.
Zurück zum Zitat Aypar E, Ozen S, Okur H et al. (2003) Th1 polarization in familial Mediterranean fever. J Rheumatol 30(9): 2011–3 Sep Aypar E, Ozen S, Okur H et al. (2003) Th1 polarization in familial Mediterranean fever. J Rheumatol 30(9): 2011–3 Sep
14.
Zurück zum Zitat Berer A, Stockl J, Majdic O et al (2000) 1, 25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol 28:575–583PubMedCrossRef Berer A, Stockl J, Majdic O et al (2000) 1, 25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol 28:575–583PubMedCrossRef
15.
Zurück zum Zitat Helming L, Bose J, Ehrchen J et al (2005) 1 alpha, 25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation. Blood 106:4351–4358PubMedCrossRef Helming L, Bose J, Ehrchen J et al (2005) 1 alpha, 25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation. Blood 106:4351–4358PubMedCrossRef
16.
Zurück zum Zitat Mahon BD, Wittke A, Weaver V et al (2003) The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 89:922–932PubMedCrossRef Mahon BD, Wittke A, Weaver V et al (2003) The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 89:922–932PubMedCrossRef
17.
Zurück zum Zitat Mattner F, Smiroldo S, Galbiati F et al (2000) Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1, 25-dihydroxyvitamin D(3). Eur J Immunol 30:498–508PubMedCrossRef Mattner F, Smiroldo S, Galbiati F et al (2000) Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1, 25-dihydroxyvitamin D(3). Eur J Immunol 30:498–508PubMedCrossRef
18.
Zurück zum Zitat Cantorna MT, Woodward WD, Hayes CE et al (1998) 1, 25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. J Immunol 160:5314–5319PubMed Cantorna MT, Woodward WD, Hayes CE et al (1998) 1, 25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. J Immunol 160:5314–5319PubMed
19.
Zurück zum Zitat Staeva-Vieira TP, Freedman LP (2002) 1, 25-Dihydroxyvitamin D3 inhibits IFN-gamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. J Immunol 168:1181–1189PubMed Staeva-Vieira TP, Freedman LP (2002) 1, 25-Dihydroxyvitamin D3 inhibits IFN-gamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. J Immunol 168:1181–1189PubMed
Metadaten
Titel
Decreased vitamin D levels in patients with familial mediterranean fever
Publikationsdatum
01.05.2013
Erschienen in
Rheumatology International / Ausgabe 5/2013
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2278-z

Weitere Artikel der Ausgabe 5/2013

Rheumatology International 5/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.